Notice of Meeting, 49665 [2020-17789]

Download as PDF Federal Register / Vol. 85, No. 158 / Friday, August 14, 2020 / Notices Date: September 17–18, 2020. Closed: September 17, 2020, 11:00 a.m. to 12:30 p.m. Agenda: To discuss internal operations, review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 9th Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Open: September 17, 2020, 1:00 p.m. to 3:00 p.m. Agenda: To view and discuss Clearance of Concepts. Place: National Institutes of Health, One Democracy Plaza, 9th Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Open: September 18, 2020, 11:00 a.m. to 3:00 p.m. Agenda: Report from the Institute Director and other staff. Place: National Institutes of Health, One Democracy Plaza, 9th Floor, Conference Rooms 987/989, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 11, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–17858 Filed 8–13–20; 8:45 am] National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections Jkt 250001 Dated: August 11, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–17839 Filed 8–13–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES 17:29 Aug 13, 2020 Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel and Translational Science Awards (CTSA) Review. Date: September 9–10, 2020. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1080, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Victor Henriquez, Ph.D., Scientific Review Officer, Office of Scientific Director, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health 6701 Democracy Blvd., Democracy 1, Room 1080, Bethesda, MD 20892–4878, 301–435–0813, henriquv@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Substance Abuse and Mental Health Services Administration BILLING CODE 4140–01–P VerDate Sep<11>2014 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention’s (CSAP) Drug Testing Advisory Board (DTAB) will convene via web conference on September 1st, 2020, from 10:00 a.m. EDT to 5:30 p.m. EDT. The board will meet in open-session September 1st, 2020, from 10:00 a.m. EDT to 1:00 p.m. EDT to discuss the Mandatory Guidelines for Federal Workplace Drug Testing Programs with PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 49665 updates from the Department of Transportation and the Nuclear Regulatory Commission. Other discussion topic include an update on marijuana studies and efforts. The board will meet in closed-session on September 1st, 2020, from 2:00 p.m. EDT to 5:30 p.m. EDT to discuss confidential issues surrounding the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs (hair), preliminary and unpublished studies from the Johns Hopkins University Behavioral Pharmacology Research Unit (BPRU), additional drugs (fentanyl and methadone) that may be tested for in the future, and lastly, emerging issues on marijuana. Therefore, the portion of the meeting on September 1st, 2020, from 2:00 p.m. EDT to 5:30 p.m. EDT, is closed to the public, as determined by the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). Meeting registration information can be completed at http:// snacregister.samhsa.gov/ MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https://www.samhsa.gov/ about-us/advisory-councils/meetings or by contacting the Designated Federal Officer, Jennifer Fan. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: September 1, 2020, from 10:00 a.m. to 1:00 p.m. EDT: OPEN. September 1, 2020, from 2:00 p.m. to 5:30 p.m. EDT: CLOSED. Place: Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Contact: Jennifer Fan, Senior Pharmacist, Center for Substance Abuse Prevention, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: (240) 276–1759, Email: jennifer.fan@samhsa.hhs.gov. Anastasia Marie Donovan, Policy Analyst. [FR Doc. 2020–17789 Filed 8–13–20; 8:45 am] BILLING CODE 4162–20–P E:\FR\FM\14AUN1.SGM 14AUN1

Agencies

[Federal Register Volume 85, Number 158 (Friday, August 14, 2020)]
[Notices]
[Page 49665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17789]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on September 1st, 2020, 
from 10:00 a.m. EDT to 5:30 p.m. EDT.
    The board will meet in open-session September 1st, 2020, from 10:00 
a.m. EDT to 1:00 p.m. EDT to discuss the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs with updates from the 
Department of Transportation and the Nuclear Regulatory Commission. 
Other discussion topic include an update on marijuana studies and 
efforts. The board will meet in closed-session on September 1st, 2020, 
from 2:00 p.m. EDT to 5:30 p.m. EDT to discuss confidential issues 
surrounding the proposed Mandatory Guidelines for Federal Workplace 
Drug Testing Programs (hair), preliminary and unpublished studies from 
the Johns Hopkins University Behavioral Pharmacology Research Unit 
(BPRU), additional drugs (fentanyl and methadone) that may be tested 
for in the future, and lastly, emerging issues on marijuana. Therefore, 
the portion of the meeting on September 1st, 2020, from 2:00 p.m. EDT 
to 5:30 p.m. EDT, is closed to the public, as determined by the 
Assistant Secretary for Mental Health and Substance Use, SAMHSA, in 
accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, 
Section 10(d).
    Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Jennifer Fan.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: September 1, 2020, from 10:00 a.m. to 1:00 p.m. 
EDT: OPEN. September 1, 2020, from 2:00 p.m. to 5:30 p.m. EDT: CLOSED.
    Place: Substance Abuse and Mental Health Services Administration, 
5600 Fishers Lane, Rockville, MD 20857.
    Contact: Jennifer Fan, Senior Pharmacist, Center for Substance 
Abuse Prevention, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 
20857, Telephone: (240) 276-1759, Email: [email protected].

Anastasia Marie Donovan,
Policy Analyst.
[FR Doc. 2020-17789 Filed 8-13-20; 8:45 am]
BILLING CODE 4162-20-P